Beth Anne Allison

Title: Beth Anne Allison: Innovator in Photodynamic Therapy

Introduction

Beth Anne Allison is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of medical technology, particularly in the area of photodynamic therapy (PDT). With a total of 3 patents, her work focuses on innovative solutions to prevent complications in vascular access.

Latest Patents

One of her latest patents is titled "Use of low-dose PDT to inhibit restenosis." This invention relates to the application of low-dose photodynamic therapy to prevent, treat, inhibit, or reduce restenosis in blood vessels. The technology can be utilized in conjunction with any angioplastic procedure to prevent restenosis or decrease intima thickness, thereby reducing luminal narrowing. Another significant patent is "Use of PDT to inhibit intimal hyperplasia." This invention addresses the challenges faced by long-term dialysis patients who require safe and reliable vascular access, often through an arteriovenous (AV) fistula. The primary cause of AV fistula loss is stenosis due to intimal hyperplasia. This patent discloses methods of using photodynamic therapy to inhibit intimal hyperplasia and smooth muscle cell growth at the anastomosis of an AV fistula in vivo.

Career Highlights

Beth Anne Allison has worked with the University of British Columbia, where she has contributed to research and development in her field. Her innovative approaches have garnered attention and respect within the medical community.

Collaborations

Throughout her career, she has collaborated with notable professionals, including Philippe Maria Clotaire Margaron and Anna M Richter. These partnerships have further enhanced her research and development efforts.

Conclusion

Beth Anne Allison is a trailblazer in the field of photodynamic therapy, with a focus on improving vascular access for patients. Her inventions and collaborations reflect her commitment to advancing medical technology and patient care.